CarsonAllaria Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-75
Closed -$1.44K 375
2025
Q1
$1.44K Hold
75
﹤0.01% 334
2024
Q4
$2.7K Hold
75
﹤0.01% 303
2024
Q3
$3.18K Hold
75
﹤0.01% 323
2024
Q2
$3.02K Hold
75
﹤0.01% 311
2024
Q1
$2.66K Hold
75
﹤0.01% 321
2023
Q4
$2.22K Hold
75
﹤0.01% 298
2023
Q3
$1.56K Hold
75
﹤0.01% 314
2023
Q2
$1.84K Hold
75
﹤0.01% 324
2023
Q1
$3.05K Buy
+75
New +$3.1K ﹤0.01% 284

Other funds holding TNDM

CarsonAllaria Wealth Management's TNDM Position: Q2 2025 in Review

CarsonAllaria Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 75 shares — an estimated $1.44K sold.

CarsonAllaria Wealth Management first reported a position in TNDM in Q1 2023 and held it in 9 quarters. The position peaked at $3.18K in Q3 2024. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • CarsonAllaria Wealth Management reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 75 Tandem Diabetes Care shares in Q2 2025, an estimated $1.44K.
  • CarsonAllaria Wealth Management first reported a position in Tandem Diabetes Care in Q1 2023 and held it in 9 quarters.
  • CarsonAllaria Wealth Management's Tandem Diabetes Care position peaked at $3.18K in Q3 2024.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q2 2025, filed 24 Jul 2025.